All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
IHE real return snapshot: after CPI-U inflation, IHE returned +46.75% over the past year and +13.38% YTD, with dividends reinvested. Since May 5, 2006, IHE is up +378.57% in real purchasing-power return, or +8.08%/yr, and is currently at its real total-return high.
Data ending Fri Jun. 26, 2026
| Fri 2006-05-05š¬ to Fri 2026-06-26 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| IHE × |
+13.38%
2026-06-26 |
+46.75%
2026-06-26 |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Fri 2006-05-05š¬ to Fri 2026-06-26 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| IHE × |
+378.57%
+8.08%/yr |
+7.99%/yr
(R2=0.823) |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Fri 2006-05-05š¬ to Fri 2026-06-26 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| IHE × |
$10,000.00
2006-05-05 |
$47,856.86
2026-06-26 |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Year | IHE |
|---|---|
| 2026 (YTD) | +13.38% |
| 2025 | +28.26% |
| 2024 | +5.10% |
| 2023 | ā2.21% |
| 2022 | ā10.65% |
| 2021 | +5.63% |
| 2020 | +12.13% |
| 2019 | +12.89% |
| 2018 | ā9.49% |
| 2017 | +8.35% |
| 2016 | ā13.54% |
| 2015 | +8.02% |
| 2014 | +28.93% |
| 2013 | +38.51% |
| 2012 | +11.45% |
| 2011 | +17.46% |
| 2010 | +11.05% |
| 2009 | +26.66% |
| 2008 | ā15.00% |
| 2007 | ā1.66% |
| 2006 | +6.44% |
| Fri 2006-05-05š¬ to Fri 2026-06-26 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| IHE × | — |
ā39.57%
2009-03-05 from 2007-05-22 peak |
||||
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
| Period ending Fri 2026-06-26 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| IHE × | +46.75% |
+43.12% +19.63%/yr |
+60.81% +17.16%/yr |
+39.50% +6.88%/yr |
+78.54% +5.97%/yr |
|
| iShares U.S. Pharmaceuticals ETF Exchange-Traded Fund | ||||||
